Can a Multi-Epitope Vaccine be a solution for COVID-19 pandemic?

Main Author: Domina Petric
Format: info publication-preprint Journal
Terbitan: , 2021
Online Access: https://zenodo.org/record/5233404
ctrlnum 5233404
fullrecord <?xml version="1.0"?> <dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><creator>Domina Petric</creator><date>2021-08-22</date><description>Problems associated with Wuhan spike protein-based vaccines are the emergence of new SARS-CoV-2 strains that are more or less resistant to Wuhan spike protein-based vaccine-induced immunity, and toxicity of the spike protein (S protein alone can damage vascular endothelial cells). Multi-epitope vaccine against SARS-CoV-2, excluding the spike protein, could potentially be less toxic than Wuhan spike protein-based vaccines with less serious side effects, but still enough immunogenic to elicit protective immune response. Another potential benefit of a multi-epitope COVID-19 vaccine is that, taking into account the fact that most of the new SARS-CoV-2 strains carry significant new mutations in the spike protein and less significant mutations in other structural proteins of the virus, it could provide more potent immune response against new SARS-CoV-2 variants.</description><identifier>https://zenodo.org/record/5233404</identifier><identifier>10.5281/zenodo.5233404</identifier><identifier>oai:zenodo.org:5233404</identifier><relation>doi:10.5281/zenodo.5233403</relation><relation>url:https://zenodo.org/communities/covid-19</relation><rights>info:eu-repo/semantics/openAccess</rights><rights>https://creativecommons.org/licenses/by/4.0/legalcode</rights><title>Can a Multi-Epitope Vaccine be a solution for COVID-19 pandemic?</title><type>Other:info:eu-repo/semantics/preprint</type><type>Other:publication-preprint</type><recordID>5233404</recordID></dc>
format Other:info:eu-repo/semantics/preprint
Other
Other:publication-preprint
Journal:Journal
Journal
author Domina Petric
title Can a Multi-Epitope Vaccine be a solution for COVID-19 pandemic?
publishDate 2021
url https://zenodo.org/record/5233404
contents Problems associated with Wuhan spike protein-based vaccines are the emergence of new SARS-CoV-2 strains that are more or less resistant to Wuhan spike protein-based vaccine-induced immunity, and toxicity of the spike protein (S protein alone can damage vascular endothelial cells). Multi-epitope vaccine against SARS-CoV-2, excluding the spike protein, could potentially be less toxic than Wuhan spike protein-based vaccines with less serious side effects, but still enough immunogenic to elicit protective immune response. Another potential benefit of a multi-epitope COVID-19 vaccine is that, taking into account the fact that most of the new SARS-CoV-2 strains carry significant new mutations in the spike protein and less significant mutations in other structural proteins of the virus, it could provide more potent immune response against new SARS-CoV-2 variants.
id IOS16997.5233404
institution ZAIN Publications
institution_id 7213
institution_type library:special
library
library Cognizance Journal of Multidisciplinary Studies
library_id 5267
collection Cognizance Journal of Multidisciplinary Studies
repository_id 16997
subject_area Multidisciplinary
city Stockholm
province INTERNASIONAL
shared_to_ipusnas_str 1
repoId IOS16997
first_indexed 2022-06-06T06:54:40Z
last_indexed 2022-06-06T06:54:40Z
recordtype dc
_version_ 1734910591992070144
score 17.538404